|
Volumn 51, Issue 1318, 2009, Pages 62-63
|
Tablet splitting
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE PLUS ATORVASTATIN;
AMLODIPINE PLUS OLMESARTAN;
AMOXICILLIN PLUS CLAVULANIC ACID;
ATORVASTATIN;
AVALIDE;
EZETIMIBE PLUS SIMVASTATIN;
HYDROCHLOROTHIAZIDE PLUS IRBESARTAN;
LISINOPRIL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METFORMIN PLUS SITAGLIPTIN;
METOPROLOL;
PERCOCET;
RISPERIDONE;
SIMVASTATIN;
UNCLASSIFIED DRUG;
WARFARIN;
DRUG;
CHOLESTEROL BLOOD LEVEL;
DIASTOLIC BLOOD PRESSURE;
DRUG COST;
DRUG MANUFACTURE;
DRUG SUBSTITUTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERTENSION;
NEAR INFRARED SPECTROSCOPY;
PATIENT COMPLIANCE;
QUALITY CONTROL;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
SHORT SURVEY;
SWALLOWING;
SYSTOLIC BLOOD PRESSURE;
TABLET;
ARTICLE;
CHEMISTRY;
CLINICAL TRIAL;
COST CONTROL;
ECONOMICS;
METHODOLOGY;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS AS TOPIC;
COST SAVINGS;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
QUALITY CONTROL;
TABLETS;
|
EID: 68849114031
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (2)
|
References (12)
|